Shield Therapeutics upbeat as Accrufer trial initiated in Japan
(Alliance News) - Shield Therapeutics PLC on Friday reported the commencement of a phase two Accrufer trial in Japan for the treatment of pulmonary arterial hypertension. Read More
| Price | 10.70p on 15-12-2025 at 17:15:08 |
|---|---|
| Change | 0.45p 4.39% |
| Buy | 10.90p |
| Sell | 10.50p |
| Last Trade: | Buy 100.00 at 10.80p |
| Day's Volume: | 915,771 |
| Last Close: | 10.70p |
| Open: | 10.25p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.15p - 10.70p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £113.61m |
| VWAP: | 10.34569p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100 | 10.80p | Ordinary |
16:27:39 - 15-Dec-25 |
| Buy* | 4,800 | 10.80p | Ordinary |
16:24:04 - 15-Dec-25 |
| Sell* | 20 | 10.50p | Ordinary |
16:16:25 - 15-Dec-25 |
| Buy* | 45,871 | 10.80p | Ordinary |
16:16:08 - 15-Dec-25 |
| Buy* | 110,000 | 10.50p | Ordinary |
16:11:24 - 15-Dec-25 |
| Buy* | 238 | 10.50p | Ordinary |
15:53:56 - 15-Dec-25 |
| Buy* | 36,313 | 10.285p | Ordinary |
15:49:58 - 15-Dec-25 |
| Buy* | 38,741 | 10.325p | Ordinary |
15:49:39 - 15-Dec-25 |
| Sell* | 95 | 10.00p | SI Trade |
15:45:34 - 15-Dec-25 |
| Buy* | 51,674 | 10.45p | Ordinary |
15:41:04 - 15-Dec-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Dec 2025 7:00 am | RNS-R | Shield Wins Gold at Titan Branding Awards |
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |
| 7th Nov 2025 7:03 am | RNS | ACCRUFeR receives Authorisation by Korean Ministry |
| 23rd Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |